Actively Recruiting
Feasibility, Acceptability and Preliminary Efficacy of the New Iteration of the Innovative Smartphone-based Care Solution for Women With Breast Cancer Undergoing Chemotherapy (iCareBreast+): A Pilot Study Research Proposal
Led by National Cancer Centre, Singapore · Updated on 2025-09-12
40
Participants Needed
1
Research Sites
23 weeks
Total Duration
On this page
Sponsors
N
National Cancer Centre, Singapore
Lead Sponsor
B
Buddy Healthcare Ltd OY
Collaborating Sponsor
AI-Summary
What this Trial Is About
The overall aim of the study is to evaluate the feasibility, acceptability and preliminary effects of the next iteration of iCareBreast+, an innovative breast care e-support intervention programme, by refining existing contents and building new contents based on comprehensive assessment of breast cancer women's needs and preferences among breast cancer patients undergoing chemotherapy. The specific objectives of this study are: 1. To develop a new iteration of an innovative smartphone-based self-care solution for patients with breast cancer undergoing chemotherapy (iCareBreast+); 2. To assess the feasibility and acceptability of iCareBreast+; and 3. To explore the preliminary effects of iCareBreast+ on the primary outcome of self-efficacy, and knowledge of breast cancer treatment, as well as secondary outcomes including anxiety, depression, health-related quality of life (HRQoL), social support and satisfaction with oncologic care.
CONDITIONS
Official Title
Feasibility, Acceptability and Preliminary Efficacy of the New Iteration of the Innovative Smartphone-based Care Solution for Women With Breast Cancer Undergoing Chemotherapy (iCareBreast+): A Pilot Study Research Proposal
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Women aged 21 years or older at recruitment
- Diagnosed with stage 1 to 3 breast cancer
- Starting chemotherapy for the first time or up to 4 cycles of chemotherapy
- Able to speak, read, and write in English or Mandarin
- Have access to and able to use a smartphone
You will not qualify if you...
- History of or currently having other types of cancer
- Diagnosed with psychiatric illness such as schizophrenia, anxiety disorder, mood disorder, or impaired cognitive function
- Alcohol or substance abuse within the past year
- Receiving concurrent psychosocial interventions
- Bereavement within the last 6 months
- Currently pregnant
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
National Cancer Centre, Singapore
Singapore, Singapore
Actively Recruiting
Research Team
D
Dr Ryan Shea YC Tan, MBBS, MRCP(UK), MMed
CONTACT
B
Bernard JG Chua, MBBS (Hons)(Aus), MRCP (UK)
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here